Clinical features and treatment for reperfusion arrhythmia
- VernacularTitle:再灌注性心律失常的临床特点与治疗
- Author:
Jiaju ZHANG
;
Aidong ZHOU
- Publication Type:Journal Article
- Keywords:
Acute myocardial infarction;
Thrombolytic therapy;
Reperfusion arrhythmia;
Magnesium sulfate
- From:
Clinical Medicine of China
2000;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical features of reperfusion arrhythmia (RA) following venous thrombolytic therapy by use of Urokinase (UK) for treating acute myocardial infarction (AMI),and to evaluate the effect of magnesium agent in treating RA.Methods 107 AMI cases admitted to our hospital were treated with UK who were divided into A (n=50) and B (n=57) groups.In B magnesium agent was injected into vein 20 minutes before thrombolytic therapy.Results According to clinical criteria,69 cases were recanalyzed with a recanalyzed rate of 64.49%.Before thrombolytic therapy,arrhythmia occurred in 36 cases.Of 31 recanalyzed cases in A group,25 cases presented with RA,whereas,of 38 recanalyzed cases in B group,13 cases presented with RA (P
